Literature DB >> 17172910

Gemella haemolysans infectious crystalline keratopathy.

Mohammed K Elmallah1, Wuqaas M Munir, William M Janda, Elmer Y Tu.   

Abstract

PURPOSE: To report a case of infectious crystalline keratopathy caused by Gemella haemolysans.
METHODS: Observational case report. A 65-year-old woman underwent penetrating keratoplasty for contact lens-related Acanthamoeba keratitis and developed a nonhealing epithelial defect. Despite continued prophylaxis with topical gatifloxacin, small superficial stromal opacities were noted and cultured 6 months after penetrating keratoplasty. The opacities coalesced into a fine, crystalline keratopathy in the superficial stroma with persistent overlying epithelial defect.
RESULTS: Culture results from corneal scraping showed more than 100 colonies of G. haemolysans. Topical vancomycin was instituted, with complete resolution of the crystalline keratopathy and epithelial defect over the next 2 months.
CONCLUSIONS: G. haemolysans can be a causative organism of infectious crystalline keratopathy. This infection can arise in a postkeratoplasty patient despite prophylaxis with a fourth-generation fluoroquinolone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17172910     DOI: 10.1097/01.ico.0000240090.44195.a3

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

1.  Acute postoperative endophthalmitis by Gemella haemolysans.

Authors:  Suma Nalamada; Subhadra Jalali; Ashok Kumar Reddy
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

2.  Gemella haemolysans bacteremia in a patient with secondary peritonitis due to a duodenal ulcer perforation: A case report.

Authors:  Yoshiro Hadano; Yusuke Kinugasa; Kiyofumi Ohkusu; Kazushige Ishibashi; Miwako Isoda
Journal:  IDCases       Date:  2018-05-01

3.  A Case Report of Gemella haemolysans Keratitis After Refractive Surgery.

Authors:  Yaohua Zhai; Chenjiu Pang; Shengtao Sun; Qiufei Ma; Lei Han; Yuwei Gu; Lizhe Gu
Journal:  Infect Drug Resist       Date:  2021-12-06       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.